Siga Technologies INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Siga Technologies INC (SIGA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.23 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-10
- Siga Technologies INC share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $1.23M, a 4839.48% increase from fiscal 2024.
- Siga Technologies INC share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $24.96K, a 79.70% decline from fiscal 2023.
- Siga Technologies INC share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $123.00K, a 67.20% decline from fiscal 2022.
- Siga Technologies INC share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $375.00K, a 45.35% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $1.23M 10-K · filed 2026-03-10 |
| 2024-12-31 | $24.96K 10-K · filed 2026-03-10 |
| 2023-12-31 | $123.00K 10-K · filed 2025-03-11 |
| 2022-12-31 | $375.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $258.00K 10-K · filed 2023-03-02 |
| 2020-12-31 | $383.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |